Used topically to provide tear-like lubrication for the symptomatic relief of dry eyes and eye irritation associated
with
deficient tear production. (Usually in cases of rheumatoid arthritis, keratoconjunctivitis sicca and xerophthalmia).
Also used as an ocular lubricant for artificial eyes.

Adults, children and the elderly. The dose depends on the need for lubrication. Usually one to two drops to each
eye three times daily or as prescribed.

If irritation persists or worsens, or headache, eye pain, vision changes or continued redness occur, discontinue
use and
consult a physician.
To preserve sterility do not allow the dropper to touch the eye or any other surface.
The product contains benzalkonium chloride and should not be used when soft contact lenses are worn

None.

Fertility
Studies have not been performed to evaluate the effect of topical ocular administration of hypromellose on fertility.
Hypromellose is a pharmacologically inert compound and it would not be expected to have any effect on fertility.
Pregnancy
There are no or limited amount of data from the use of ophthalmic hypromellose in pregnant women. Systemic
exposure to hypromellose following topical ocular administration is negligible and the product has no
pharmacological properties.
Lactation
It is unknown whether topical hypromellose/metabolites are excreted in human milk. No effects on the breastfed
newborn/infant are anticipated since the systemic exposure of the breast-feeding woman to hypromellose is
negligible. In addition to this, hypromellose is pharmacologically inert.

OCULAC Eye Drops May cause transient blurring of vision on instillation.
Do not drive or operate hazardous machinery unless vision is clear.

Due to the characteristics of this preparation, no toxic effects are to be expected with an ocular overdose of this
product, nor in the event of accidental ingestion of the contents of one bottle.

Ophthalmologicals: Other ophthalmologicals
ATC code: SO1X A20
Hypromellose is an inert substance. It has no pharmacological activity.

Hypromellose is an inert substance. It has no pharmacological activity and, hence, the pharmacokinetic properties
have not been studied.

Hypromellose is an inert substance and is not expected to be absorbed systemically. Hence, although no systemic
toxicity studies have been conducted it is not expected to demonstrate any systemic toxicity or to have any effect
on reproductive processes.
Similarly, no specific local ocular toxicity or irritation studies have been conducted, however, no adverse effects
are anticipated. Indeed, hypromellose ophthalmic solution is used as a control in some ophthalmic drug studies
because of the acknowledged low level of toxicity.

Boric acid
Borax
Disodium Edetate
Benzalkonium chloride solution
Water for injection

Not applicable

Store below 25°C
Protect from light
Do not freeze

10 ml polyethylene bottle with white polyethylene cap and white pilfer proof.

None stated.